Taylor Morrison Home (TMHC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on May 22, 2025, with voting available online, by phone, or by mail for shareholders of record as of March 31, 2025.
Key proposals include electing nine directors, an advisory vote on executive compensation, and ratifying Deloitte & Touche LLP as the independent auditor for 2025.
The board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Voting matters and shareholder proposals
Shareholders will vote on the election of nine director nominees for one-year terms, an advisory say-on-pay vote, and auditor ratification.
Proposals require a majority of votes cast to pass; abstentions count as votes against, broker non-votes have no effect except for auditor ratification.
Shareholders may submit proposals for the 2026 meeting by December 12, 2025, and director nominations must follow advance notice provisions.
Board of directors and corporate governance
The board consists of nine members, eight of whom are independent; all committees are fully independent.
Board diversity, tenure, and skills are emphasized, with a fellowship program to promote diverse board candidates.
The board has an independent lead director and conducts annual self-evaluations; there is no stockholder rights plan.
Board committees include audit, compensation, and nominating/governance, each with defined charters and responsibilities.
Latest events from Taylor Morrison Home
- 2025 delivered strong earnings and margins; 2026 outlook expects margin recovery and robust capital returns.TMHC
Q4 202511 Feb 2026 - Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20255 Feb 2026 - Targeting 20,000 closings by 2028 with digital innovation, margin focus, and brand expansion.TMHC
Investor Day 20253 Feb 2026 - Q2 2024 delivered 3,200 closings, $1.99B revenue, and raised full-year guidance.TMHC
Q2 20243 Feb 2026 - Q3 net income up 54% to $251M, with record revenue, margin gains, and strong outlook.TMHC
Q3 202419 Jan 2026 - Double-digit growth in closings and revenue, with strong margins and 2025 outlook.TMHC
Q4 202411 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with online voting.TMHC
Proxy Filing1 Dec 2025 - Q1 2025 delivered 12% revenue growth, margin expansion, and strong liquidity.TMHC
Q1 202529 Nov 2025 - Q2 2025: 3,340 homes, $2.0B+ revenue, 23% margin, net sales orders down 12%, strong liquidity.TMHC
Q2 202530 Oct 2025